Profile

QurCan Therapeutics is advancing the next wave of genetic medicines for CNS diseases with TERP (Target-Engineered Responsive Polymer) technology, a non-viral delivery platform enabling safe, repeat intravenous delivery of RNA and biologics to the brain.

QurCan Therapeutics logo

Website

qurcan.com

Contact


Event details

Date: November 3 - 5, 2025

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

22 in total